SCHEMBL3811083

SCHEMBL3811083

COc1ccc(OC)c(S(=O)(=O)N(Cc2ccccc2)[C@@H]2CCN(C#N)C2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 2/20 0.56
CTSS P25774 2/20 0.56
CTSK P43235 2/20 0.56
CTSC P53634 2/20 0.56
CTSB P07858 1/20 0.56
KMT2A Q03164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ALDH1A1 P00352 6/20 0.45
POLB P06746 1/20 0.44
USP30 Q70CQ3 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 1/20 0.44
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
F10 P00742 1/20 0.41
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3811475 0.94 CTSL (0.55) CTSLCTSSCTSKCTSCCTSB
SCHEMBL3838249 0.92 CTSL (0.55) CTSLCTSSCTSKCTSCCTSB
SCHEMBL3808433 0.92 CTSL (0.55) CTSLCTSSCTSKCTSCCTSB
SCHEMBL3810713 0.91 CTSL (0.52) CTSLCTSSCTSKCTSCCTSB
SCHEMBL3810290 0.91 CTSL (0.54) CTSLCTSSCTSKCTSCCTSB
SCHEMBL3811496 0.91 CTSL (0.54) CTSLCTSSCTSKCTSCCTSB
SCHEMBL3808181 0.90 CTSL (0.52) CTSLCTSSCTSKCTSCCTSB
SCHEMBL3810701 0.90 CTSL (0.53) CTSLCTSSCTSKCTSCCTSB
SCHEMBL3806619 0.90 CTSL (0.57) CTSLCTSSCTSKCTSCCTSB
SCHEMBL3814208 0.90 L3MBTL1 (0.44) CTSLCTSSCTSKCTSCCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264498-A1 Cathepsin C Inhibitors GLAXO GROUP LIMITED (GB) 2009-10-22 US claimed
US-20090264498-A1 Cathepsin C Inhibitors GLAXO GROUP LIMITED (GB) 2009-10-22 US disclosed
WO-2009129365-A1 CATHEPSIN C INHIBITORS GLAXO GROUP LIMITED (GB) 2009-10-22 WO disclosed
US-20090264498-A1 Cathepsin C Inhibitors GLAXO GROUP LIMITED (GB) 2009-10-22 US disclosed
US-20090264498-A1 Cathepsin C Inhibitors GLAXO GROUP LIMITED (GB) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264498-A1 Cathepsin C Inhibitors CTSF, CTSZ, CTSG CTSL 9/4885CTSS 5/4885CTSK 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.